Filing metadata

Accession number
0000950170-24-091952
Form type
Form 3
Filer
CNS Pharmaceuticals, Inc.
CIK
CIK 1729427
Filed
Aug 06, 2024
Reporting period
Jul 29, 2024
Description
Initial ownership

Explore SEC Filings Hub